Cost burden and net monetary benefit loss of neonatal hypoglycaemia
Background Neonatal hypoglycaemia is a common but treatable metabolic disorder that affects newborn infants and which, if not identified and treated adequately, may result in neurological sequelae that persist for the lifetime of the patient.
Matthew J. Glasgow +2 more
doaj +1 more source
Glucokinase activating mutation causing hypoglycaemia diagnosed late in adult who fasts for Ramadhan
Activating mutation of glucokinase gene (GCK) causes resetting of insulin inhibition at a lower glucose threshold causing hyperinsulinaemic hypoglycaemia (GCK-HH).
Wann Jia Loh +6 more
doaj +1 more source
Hypoglycaemia in older home-dwelling people with diabetes- a scoping review
Background Hypoglycaemia is associated with cognitive and functional decline in older people with diabetes. Identification of individuals at risk and prevention of hypoglycaemia is therefore an important task in the management of diabetes in older home ...
Monica Hermann +5 more
doaj +1 more source
The associations of sedentary time and breaks in sedentary time with 24-hour glycaemic control in type 2 diabetes [PDF]
The aim of this study was to investigate the associations of accelerometer-assessed sedentary time and breaks in sedentary time with 24-h events and duration of hypoglycaemia (7.8 mmol/l) and above target glucose (>9 mmol/l).
Assah +51 more
core +3 more sources
Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness. [PDF]
Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas.
Eleonora Seelig +4 more
doaj +1 more source
The management of type 2 diabetes with fixed‐ratio combination insulin degludec/liraglutide (IDegLira) versus basal‐bolus therapy (insulin glargine U100 plus insulin aspart): a short‐term cost‐effectiveness analysis in the UK setting [PDF]
Aim: To evaluate the cost‐effectiveness of IDegLira versus basal‐bolus therapy (BBT) with insulin glargine U100 plus up to 4 times daily insulin aspart for the management of type 2 diabetes in the UK.
ADVANCE Collaborative Group +47 more
core +1 more source
A Case of Insulinoma with Improved Reactive Hypoglycaemia after Operation [PDF]
It is well known that fasting hypoglycaemia is common in insulinoma, but postprandial hypoglycaemia has also been reported. In almost all cases, the serum Immunoreactive Insulin (IRI) level is not suppressed.
Shunsuke Funazaki +3 more
doaj +1 more source
Endocrine and metabolic emergencies: hypoglycaemia
Hypoglycaemia is rare in healthy individuals owing to the numerous elegant hormonal and neuronal mechanisms that maintain glucose homeostasis. Glucose is an obligate metabolic fuel for cerebral tissue and therefore hypoglycaemia, if uncorrected, can have
Elora Mukherjee +2 more
doaj +1 more source
Brain injury due to persistent hyperinsulinemic hypoglycemia of infancy [PDF]
A
De Visschere, Pieter +3 more
core +2 more sources
Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia [PDF]
Aims: Inpatient hypoglycaemia is common and associated with adverse outcomes. There is often increased vigilance of hypoglycaemia in inpatients with type 1 diabetes (T1DM) compared to type 2 diabetes (T2DM).
Jones, Gregory C. +2 more
core +1 more source

